Skip to content

Research at St Andrews

Symptoms, spirometry, exhaled nitric oxide, and asthma exacerbations in clinical practice

Research output: Contribution to journalArticle

Author(s)

Daniel Menzies, Cathy Jackson, Catrina Mistry, Ruth Houston, Brian J. Lipworth, Catherine Miriam Jackson

School/Research organisations

Abstract

Background: Patient symptoms, spirometry measurements, exacerbation rates, and exhaled nitric oxide (FENO) levels have all been used to quantify asthma severity.

Objective: To determine the relationships among these disease Surrogates in clinical practice.

Methods: Data were collected from 5 primary care asthma clinics on patient symptoms, reliever use, spirometry measurements, maintenance pharmacotherapy, disease severity (British Thoracic Society treatment step), and FENO level. Exacerbation data (asthma-related unscheduled health care contact or rescue oral corticosteroid therapy) for the 12 months before and 3 months after the clinic visit were then obtained.

Results: A total of 267 adult asthmatic patients (mean [SEM] age, 51.6 [1.1] years; forced expiratory volurne in 1 second, 86.3% [1.2%] of predicted) participated, and 157 exacerbations were captured. For the 12 months before the clinic visit, exacerbation rate was positively correlated with dose of inhaled corticosteroid (P <.001), treatment step (P <.001), reliever use (P =.002), and symptom score (P <.001) but was negatively correlated with FENO level (P =.04); only symptom scores correlated with exacerbation rate in the 3 months after the visit. Levels of FENO were significantly lower in frequently exacerbating patients receiving higher doses of maintenance inhaled corticosteroids compared with patients with mild disease who were corticosteroid naive (19.7 vs 40.4 ppb, P <.001). Measurement of FENO was an insensitive method (sensitivity, 66.7%; specificity, 51.9% at a cutoff value of 20 ppb) for identifying patients who subsequently exacerbated.

Conclusion: Levels of FENO are paradoxically decreased in patients with more severe asthma and frequent exacerbations and may, therefore, be of limited utility in primary care.

Close

Details

Original languageEnglish
Pages (from-to)248-255
Number of pages8
JournalAnnals of Allergy Asthma & Immunology
Volume101
Issue number3
Publication statusPublished - Sep 2008

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by journal

  1. Antimicrobial resistance in atopic dermatitis: need for an urgent rethink

    Harkins, C. P., Holden, M. T. G. & Irvine, A. D., Mar 2019, In : Annals of Allergy Asthma & Immunology. 122, 3, p. 236-240 5 p.

    Research output: Contribution to journalArticle

  2. The effects of butterbur on the histamine and allergen cutaneous response

    Jackson, C. M., Lee, D. K. C. & Lipworth, B. J., Feb 2004, In : Annals of Allergy Asthma & Immunology. 92, 2, p. 250-254 5 p.

    Research output: Contribution to journalArticle

  3. Determinants of airway hyperresponsiveness in mild asthma

    Currie, G. P., Jackson, C. M., Lee, D. K. C. & Lipworth, B. J., May 2003, In : Annals of Allergy Asthma & Immunology. 90, 5, p. 560-563 4 p.

    Research output: Contribution to journalArticle

  4. Lung bioavailability of spacers

    Jackson, C. & Lipworth, B., Jun 2003, In : Annals of Allergy Asthma & Immunology. 90, 6, p. 674-674 1 p.

    Research output: Contribution to journalLetter

ID: 25752626

Top